Abstract

VAMP7 (vesicle-associated membrane protein) belongs to the intracellular membrane fusion SNARE (Soluble N-ethylmaleimide-sensitive factor attachment protein receptors) protein family. In this study, we used CRISPR/Cas9 genome editing technology to generate VAMP7 knockout (KO) human HeLa cells and mouse KO brain extracts in order to test the specificity and the background of a set of commercially available and homemade anti-VAMP7 antibodies. We propose a simple profiling method to analyze western blotting and immunocytochemistry staining profiles and determine the extent of the antibodies' specificity. Using this method, we were able to rank the performance of a set of available antibodies and further showed an optimized procedure for VAMP7 immunoprecipitation, which we validated using wild-type and KO mouse brain extracts.

Highlights

  • Intracellular membrane fusion in the secretory and endocytic pathways relies on SNARE proteins for membrane fusion events

  • VAMP7 is a clostridial neurotoxininsensitive v-SNARE that belongs to the “Longin” subfamily: it encompasses an amino-terminal extension, the Longin domain, which acts as an auto-regulatory domain[1]

  • VAMP7 exocytosis was shown to be regulated by an integrin, FAK, and Src-dependent mechanism in developing neurons[11] and its transport to the cell periphery by VARP, Rab[21] and Kif[57], while retrograde transport depends on LRRK112

Read more

Summary

16 Oct 2018

University of Guelph, This article is included in the Antibody Validations gateway. Any reports and responses or comments on the article can be found at the end of the article

Introduction
Material and methods
Findings
Discussion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.